Search

Find exactly what you’re looking for.
Search

Showing 1-7 of 7 results

Artificial Intelligence (AI) is rapidly transforming the healthcare landscape, promising to revolutionize diagnosis, treatment, and patient care. From drug discovery to surgical precision, AI’s potential benefits are immense. However, the integration of AI into medicine also raises significant legal...

Josh Pasker, Vice Chair of Saul Ewing's Public Finance Practice, will be speaking on May 16, 2024, during the LeadingAge Inhouse Counsel Conference. Josh's topic will be financing issues and the impact on senior living communities.

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

For More Information
Contact us